SCYNEXIS

SCYNEXIS Net Debt per Share

The Net Debt per Share of SCYNEXIS (SCYX) as of Sep 27, 2026 is -0.45 USD. In the previous year, Net Debt per Share was -1.03 USD — a change of -55.65% (higher).

Net Debt per Share

-0.45USD

YoY

-55.65%

Last updated:

Net Debt per Share of SCYNEXIS is 2026 -0.45 USD. Net Debt per Share of SCYNEXIS was 2025 -1.03 USD. It decreases by -55.65% higher compared to the previous year.

The SCYNEXIS Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
-0.69 USD
Jan 1, 2019
-0.80 USD
Jan 1, 2020
-1.74 USD
Jan 1, 2021
-1.45 USD
Jan 1, 2022
-0.59 USD
Jan 1, 2023
-1.41 USD
Jan 1, 2024
-1.03 USD
Jan 1, 2025
-0.45 USD
The SCYNEXIS Net Debt per Share history
YEARNet Debt per ShareYoY
-0.45USD-55.65%
-1.03USD-27.41%
-1.41USD+138.02%
-0.59USD-59.08%
-1.45USD-16.86%
-1.74USD+118.31%
-0.80USD+15.32%
-0.69USD-0.57%
-0.70USD-34.04%
-1.06USD-5.64%
-1.12USD+56.63%
-0.71USD—
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Net Debt per Share of SCYNEXIS is -0.45 USD in 2026.

Net Debt per Share of SCYNEXIS changed from -1.03 USD to -0.45 USD, representing a -55.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

Other — SCYNEXIS

All Key Metrics — SCYNEXIS